Literature DB >> 8512564

Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4.

Y Xu1, J Song, J F Bruno, M Berelowitz.   

Abstract

We recently reported the cloning of a somatostatin receptor (SSTR) subtype from a rat genomic library designated rSSTR4. In the present study, we report the cloning of the human SSTR4 gene. A human genomic library was screened with a 1.2 kb fragment of rSSTR4 containing the full open reading frame and a genomic clone, hSSTR4, was isolated. The deduced amino acid sequence of this clone encoded a protein of 388 amino acids and is a member of the G-protein coupled receptor superfamily. Comparison of rat and human SSTR4 sequences demonstrated 89% identity. In addition, the sequence of hSSTR4 shows 61%, 46%, and 47% sequence identity with previously identified isoforms hSSTR1, hSSTR2, and hSSTR3, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512564     DOI: 10.1006/bbrc.1993.1673

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Molecular cloning of a functional human galanin receptor.

Authors:  E Habert-Ortoli; B Amiranoff; I Loquet; M Laburthe; J F Mayaux
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 2.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

Authors:  I Shimon; J E Taylor; J Z Dong; R A Bitonte; S Kim; B Morgan; D H Coy; M D Culler; S Melmed
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 4.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 5.  Molecular pharmacology of somatostatin receptors.

Authors:  D Hoyer; H Lübbert; C Bruns
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.

Authors:  L Buscail; J P Estève; N Saint-Laurent; V Bertrand; T Reisine; A M O'Carroll; G I Bell; A V Schally; N Vaysse; C Susini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 7.  Drug design at peptide receptors: somatostatin receptor ligands.

Authors:  Jason P Hannon; Caroline Nunn; Barbara Stolz; Christians Bruns; Gisbert Weckbecker; Ian Lewis; Thomas Troxler; Konstanze Hurth; Daniel Hoyer
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

8.  Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Authors:  M John; W Meyerhof; D Richter; B Waser; J C Schaer; H Scherübl; J Boese-Landgraf; P Neuhaus; C Ziske; K Mölling; E O Riecken; J C Reubi; B Wiedenmann
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

9.  Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues.

Authors:  S Jonas; M John; J Boese-Landgraf; R Häring; G Prevost; F Thomas; S Rosewicz; E O Riecken; B Wiedenmann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

10.  Delineation of the peptide binding site of the human galanin receptor.

Authors:  K Kask; M Berthold; U Kahl; G Nordvall; T Bartfai
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.